What did we learn from GDS2015? An overview of our key findings Dr Adam R Winstock, Founder Director GDS
Bibliography: All Publications
The new Psychoactive Substances Bill – a quick introduction
This blog attempts to briefly identify key components of the Bill and describe what it is proposing, as well as offering a few initial commentary notes (Centre for Public Health)
Opioid trafficking routes from Asia to Europe
Part of the Perspectives on Drugs (PODs) series, launched as part of the European Drug Report package, these designed-for-the-web interactive analyses provide deeper insights into a selection of important issues (EMCDDA)
The Global Drug Survey 2015 findings
What did we learn from GDS2015? An overview of our key findings Dr Adam R Winstock, Founder Director GDS
The misuse of benzodiazepines among high-risk opioid users in Europe
As we describe below, available evidence shows that the misuse of benzodiazepines contributes to morbidity and mortality among high-risk opioid users (EMCDDA)
Opioid trafficking routes from Asia to Europe
Part of the Perspectives on Drugs (PODs) series, launched as part of the European Drug Report package, these designed-for-the-web interactive analyses provide deeper insights into a selection of important issues (EMCDDA)
A blanket ban on psychoactive substances makes UK drugs policy even worse
This law will probably (at least initially) wipe out the high street ‘head shops’ which the Daily Mail and Centre for Social Justice are so concerned about. However, banning something has never yet simply made a drug disappear (Adam Smith Institute)
The Death Penalty for Drug Offences: What do the international drug control treaties say about ‘most serious crimes’?
By Dr Rick Lines. Executive Director of Harm Reduction International, and a Visiting Fellow at the Human Rights Centre, University of Essex
Methamphetamine deaths increase across Australia and ice use jumps by 52 per cent among people who inject drugs
Deaths involving methamphetamine have been steadily increasing since 2010 and its use among injecting drug users has increased by 50 per cent over the past 10 years, according to research from the National Drug and Alcohol Research Centre at UNSW
European Drug Report 2015
Multi media package (EMCDDA)
Laws prohibiting peer distribution of injecting equipment in Australia
A critical analysis of their effects (Drug Policy)
Drug consumption rooms
Part of the Perspectives on Drugs (PODs) series, launched as part of the European Drug Report package, these designed-for-the-web interactive analyses provide deeper insights into a selection of important issues (EMCDDA)
Drug consumption rooms
Part of the Perspectives on Drugs (PODs) series, launched as part of the European Drug Report package, these designed-for-the-web interactive analyses provide deeper insights into a selection of important issues (EMCDDA)
Expanding synthetic drugs market inhibiting development in East and South-East Asia and Oceania
The demand for synthetic drugs in East and South-East Asia and Oceania continues to rise, while rapid economic integration is creating new opportunities for transnational criminal groups to expand the illicit drug trade, warned UNODC in a new report recently released under the Global Synthetics Monitoring: Analyses, Reporting and Trends (SMART) Programme (UNODC)
European Drug Report 2015: Trends and Developments
This years’ annual review reflects on 20 years of monitoring and examines the global influences and local ramifications of Europe’s ever-changing drugs problem (EMCDDA)
Psychoactive substances bill European convention on human rights
Memorandum by the (Home Office)
Opioid trafficking routes from Asia to Europe
Part of the Perspectives on Drugs (PODs) series, launched as part of the European Drug Report package, these designed-for-the-web interactive analyses provide deeper insights into a selection of important issues (EMCDDA)
Global policy and access to new hepatitis C therapies for people who inject drugs
This review outlines policy recommendations made in the 2014 World Health Organisation (WHO) Guidelines on Screening, Care and Treatment of HCV and their relevance to PWID (Drug Policy)
Global policy and access to new hepatitis C therapies for people who inject drugs
This review outlines policy recommendations made in the 2014 World Health Organisation (WHO) Guidelines on Screening, Care and Treatment of HCV and their relevance to PWID (Drug Policy)
Global policy and access to new hepatitis C therapies for people who inject drugs
This review outlines policy recommendations made in the 2014 World Health Organisation (WHO) Guidelines on Screening, Care and Treatment of HCV and their relevance to PWID (Drug Policy)
- « Previous Page
- 1
- …
- 83
- 84
- 85
- 86
- 87
- …
- 97
- Next Page »